Assessment of serum levels of osteopontin, selenium and prolactin in patients with psoriasis compared with healthy controls, and their association with psoriasis severity

Assessment of serum levels of osteopontin, selenium and prolactin in patients with psoriasis compared with healthy controls, and their association with psoriasis severity

Summary Background The association between psoriasis and cardiovascular diseases is well documented, but the underlying mechanisms remain unknown. Overexpression of osteopontin (OPN) has been reported in the plasma of patients with psoriasis, with increased cardiovascular risk factors in these patie...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental dermatology Vol. 40; no. 7; pp. 741 - 746
Main Authors: Toossi, P., Sadat Amini, S. H., Sadat Amini, M. S., Partovi Kia, M., Enamzade, R., Kazeminejad, A., Esmaeily Radvar, S., Younespour, S.
Format: Journal Article
Language:English
Published: England Blackwell Publishing Ltd 01-10-2015
Oxford University Press
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers - blood
Case-Control Studies
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Metabolic disorders
Middle Aged
Osteopontin - blood
Prolactin - blood
Psoriasis
Psoriasis - blood
Selenium
Selenium - blood
Severity of Illness Index
Young Adult
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background The association between psoriasis and cardiovascular diseases is well documented, but the underlying mechanisms remain unknown. Overexpression of osteopontin (OPN) has been reported in the plasma of patients with psoriasis, with increased cardiovascular risk factors in these patients. Selenium compounds are effective in downregulating OPN expression. Objective We investigated the levels of OPN, selenium and prolactin (PRL) in psoriasis, and their association with metabolic status in patients to identify a possible link between these markers and observed comorbidities. Methods Plasma samples from 40 patients with psoriasis and 40 age‐ and sex‐matched healthy controls (HCs) were collected for ELISA. The clinical significance of plasma OPN, selenium and PRL levels in patients compared with controls was analysed in relation to metabolic disorders. Results There was no significant difference in median serum selenium levels between the two groups. Serum levels of PRL were not significantly different from those of HCs, but levels of OPN were significantly higher in patients with psoriasis than in HCs. Conclusions High plasma OPN is a predictor for occurrence of psoriasis. Our study showed that serum selenium and PRL were not decreased in patients with psoriasis, but there was a negative statistically significant correlation between OPN and selenium in all participants.
Bibliography:Skin Research Center
Shahid Beheshti University of Medical Science, Tehran, Iran
ark:/67375/WNG-8R23B2ND-6
ArticleID:CED12657
istex:9CFAB03DC078CE0BB5B98AB0F52FF1EF043EC929
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0307-6938
1365-2230
DOI:10.1111/ced.12657